スルファフェナゾール
- 関
- sulfafenazol
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/06/01 02:39:13」(JST)
[Wiki en表示]
Sulfaphenazole
|
|
Systematic (IUPAC) name |
4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Identifiers |
CAS Registry Number
|
526-08-9 N |
ATC code
|
J01ED08 S01AB05 QJ01EQ08 |
PubChem |
CID 5335 |
DrugBank |
DB06729 Y |
ChemSpider |
5144 Y |
UNII |
0J8L4V3F81 Y |
KEGG |
D01954 Y |
ChEMBL |
CHEMBL1109 Y |
Chemical data |
Formula |
C15H14N4O2S |
Molecular mass
|
314.363 g/mol |
SMILES
- O=S(=O)(c1ccc(N)cc1)Nc3ccnn3c2ccccc2
|
InChI
-
InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2 Y
Key:QWCJHSGMANYXCW-UHFFFAOYSA-N Y
|
N (what is this?) (verify) |
Sulfaphenazole (or sulfafenazol) is a sulfonamide antibacterial.[1]
References
- ^ Browne, S. G. (1961). "Trial of a long-acting sulfonamide sulfaphenazole (Orisul, Ciba), in the treatment of leprosy". International journal of Leprosy 29: 502–505. PMID 13873771. edit
Antibacterials: nucleic acid inhibitors (J01E, J01M)
|
|
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis) |
DHFR inhibitor |
- 2,4-Diaminopyrimidine
- Brodimoprim
- Diaveridine
- Iclaprim†
- Ormetoprim
- Trimethoprim#
- Tetroxoprim
|
|
Sulfonamides
(DHPS inhibitor) |
Short-
acting |
- Sulfaisodimidine
- Sulfamethizole
- Sulfadimidine
- Sulfapyridine
- Sulfafurazole
- Sulfanilamide
- Sulfathiazole
- Sulfathiourea
|
|
Intermediate-
acting |
- Sulfamethoxazole
- Sulfadiazine#
- Sulfamoxole
|
|
Long-
acting |
- Sulfadimethoxine
- Sulfadoxine
- Sulfalene
- Sulfametomidine
- Sulfametoxydiazine
- Sulfamethoxypyridazine
- Sulfaperin
- Sulfamerazine
- Sulfaphenazole
- Sulfamazone
|
|
Other/ungrouped |
- Sulfacetamide
- Sulfadicramide
- Sulfametrole
|
|
|
Combinations |
- Trimethoprim/sulfamethoxazole#
|
|
|
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication) |
1st g. |
- Cinoxacin‡
- Flumequine
- Nalidixic acid
- Oxolinic acid
- Pipemidic acid
- Piromidic acid
- Rosoxacin
|
|
Fluoro-
quinolones |
2nd g. |
- Ciprofloxacin#
- Enoxacin‡
- Fleroxacin‡
- Lomefloxacin
- Nadifloxacin
- Ofloxacin
- Norfloxacin
- Pefloxacin
- Rufloxacin
|
|
3rd g. |
- Balofloxacin
- Grepafloxacin‡
- Levofloxacin
- Pazufloxacin
- Sparfloxacin‡
- Temafloxacin‡
- Tosufloxacin
|
|
4th g. |
- Besifloxacin
- Clinafloxacin†
- Garenoxacin
- Gemifloxacin
- Moxifloxacin
- Gatifloxacin‡
- Sitafloxacin
- Trovafloxacin‡/Alatrofloxacin‡
- Prulifloxacin
|
|
Vet. |
- Danofloxacin
- Difloxacin
- Enrofloxacin
- Ibafloxacin
- Marbofloxacin
- Orbifloxacin
- Pradofloxacin
- Sarafloxacin
|
|
Related (DG) |
- Aminocoumarins: Novobiocin
|
|
|
|
Anaerobic DNA
inhibitors |
Nitro- imidazole derivatives |
- Metronidazole#
- Tinidazole
- Ornidazole
|
|
Nitrofuran derivatives |
- Nitrofurantoin#
- Furazolidone‡
- Nifurtoinol
|
|
|
RNA synthesis |
Rifamycins/
RNA polymerase |
- Rifampicin#
- Rifabutin
- Rifapentine
- Rifaximin
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Index of bacterial disease
|
|
Description |
|
|
Disease |
- Gram-positive firmicutes
- Gram-positive actinobacteria
- Gram-negative proteobacteria
- Gram-negative non-proteobacteria
- Cholera
- Tuberculosis
|
|
Treatment |
- Antibiotics
- cell wall
- nucleic acid
- mycobacteria
- protein synthesis
- other
- Antibodies
- Vaccines
|
|
|
English Journal
- Combined Contributions of Impaired Hepatic CYP2C11 and Intestinal Breast Cancer Resistance Protein Activities and Expression to Increased Oral Glibenclamide Exposure in Rats with Streptozotocin-Induced Diabetes Mellitus.
- Liu H, Liu L, Li J, Mei D, Duan R, Hu N, Guo H, Zhong Z, Liu X.SourceKey Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China. xdliu@cpu.edu.cn.
- Drug metabolism and disposition: the biological fate of chemicals.Drug Metab Dispos.2012 Jun;40(6):1104-12. Epub 2012 Mar 5.
- The purpose of this study was to evaluate the contributions of impaired cytochrome P450 and breast cancer resistance protein (BCRP) activity and expression to drug pharmacokinetics under diabetic conditions. Diabetes was induced in rats with the intraperitoneal administration of streptozocin. Gliben
- PMID 22393122
- Tolbutamide hydroxylation by hepatic microsomes from Atlantic salmon (Salmo salar L.).
- Vestergren AS, Zlabek V, Pickova J, Zamaratskaia G.SourceDepartment of Food Science, BioCenter, Swedish University of Agricultural Sciences, 750 07, Uppsala, Sweden.
- Molecular biology reports.Mol Biol Rep.2012 Jun;39(6):6867-73. Epub 2012 Feb 5.
- Metabolic transformations of two substrates for human cytochrome P450 (CYP450) 2C9, tolbutamide and diclofenac, were investigated in hepatic microsomes from Atlantic salmon (Salmo salar L.). Tolbutamide hydroxylation followed Michaelis-Menten kinetics. Mean apparent Michaelis-Menten constant (K(m))
- PMID 22311023
Japanese Journal
- 活性酸素種生成に関与するシトクロームP450の病態生理学的役割
- Sulfaphenazole Attenuates Myocardial Cell Apoptosis Accompanied With Cardiac Ischemia–Reperfusion by Suppressing the Expression of BimEL and Noxa
- Journal of pharmacological sciences 119(3), 251-259, 2012-07-20
- NAID 10030986977
- Increased Expression of Drug-metabolizing Enzymes in Human Hepatocarcinoma FLC-4 Cells Cultured on Micro-space Cell Culture Plates
Related Links
- InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15 )13-4-2-1-3-5-13/h1-11,18H,16H2 Yes Y Key:QWCJHSGMANYXCW- UHFFFAOYSA-N Yes Y. N (what is this?) (verify) ...
Related Pictures
★リンクテーブル★
[★]
スルファフェナゾール
- 関
- sulfaphenazole
[★]
- 英
- sulfaphenazole、((欧州))sulfafenazol